{"id":"https://openalex.org/W4253079720","doi":"https://doi.org/10.5639/gabij.2013.0204.047","title":"WHO leadership in public safety on biosimilars to be commended","display_name":"WHO leadership in public safety on biosimilars to be commended","publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W4253079720","doi":"https://doi.org/10.5639/gabij.2013.0204.047"},"language":"en","primary_location":{"id":"doi:10.5639/gabij.2013.0204.047","doi":"https://doi.org/10.5639/gabij.2013.0204.047","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2013.0204.047","pdf_url":"http://gabi-journal.net/wp-content/uploads/GJ-2013-4-p167-LettersToTheEditor-Dolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://gabi-journal.net/wp-content/uploads/GJ-2013-4-p167-LettersToTheEditor-Dolinar.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031560530","display_name":"Richard O. Dolinar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Richard O Dolinar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5031560530"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2874,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.60813146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"2","issue":"4","first_page":"167","last_page":"167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9009000062942505,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.09650000184774399,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-nomenclature","display_name":"drug names","score":0.7139999866485596},{"id":"https://openalex.org/keywords/world-health-organization","display_name":"World Health Organization","score":0.8740000128746033},{"id":"https://openalex.org/keywords/public-safety","display_name":"public safety","score":0.6309999823570251},{"id":"https://openalex.org/keywords/biologic-medicines","display_name":"biologic medicines","score":0.781000018119812},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9382927417755127},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.46895354986190796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3622775077819824},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3018988370895386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10512536764144897}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5639/gabij.2013.0204.047","doi":"https://doi.org/10.5639/gabij.2013.0204.047","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2013.0204.047","pdf_url":"http://gabi-journal.net/wp-content/uploads/GJ-2013-4-p167-LettersToTheEditor-Dolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.5639/gabij.2013.0204.047","doi":"https://doi.org/10.5639/gabij.2013.0204.047","is_oa":true,"landing_page_url":"https://doi.org/10.5639/gabij.2013.0204.047","pdf_url":"http://gabi-journal.net/wp-content/uploads/GJ-2013-4-p167-LettersToTheEditor-Dolinar.pdf","source":{"id":"https://openalex.org/S2764911163","display_name":"Generics and Biosimilars Initiative Journal","issn_l":"2033-6403","issn":["2033-6403","2033-6772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Generics and Biosimilars Initiative Journal","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4253079720.pdf","grobid_xml":"https://content.openalex.org/works/W4253079720.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1582019237","https://openalex.org/W2316911410","https://openalex.org/W4238350085","https://openalex.org/W2047485232","https://openalex.org/W4240869355","https://openalex.org/W2617598105","https://openalex.org/W4244946550","https://openalex.org/W1936367967","https://openalex.org/W2494801604","https://openalex.org/W2570158360"],"abstract_inverted_index":{"As":[0],"a":[1],"practicing":[2],"endocrinologist":[3],"and":[4,26],"Chairman":[5],"of":[6,33],"the":[7,18,30],"Alliance":[8],"for":[9,22,36],"Safe":[10],"Biologic":[11],"Medicines,":[12],"I":[13],"am":[14],"writing":[15],"to":[16,25],"commend":[17],"World":[19],"Health":[20],"Organization":[21],"its":[23],"attention":[24],"upcoming":[27],"action":[28],"on":[29],"important":[31],"issue":[32],"non-proprietary":[34],"names":[35],"biotech":[37],"medicines.":[38]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}